Intelligent Bio Solutions to Participate in the iAccess Virtual Best Ideas Spring Conference on March 25th and 26th
Intelligent Bio Solutions (Nasdaq: INBS), a medical technology company focused on intelligent, rapid, non-invasive testing solutions, has announced its participation in the upcoming iAccess Alpha Virtual Best Ideas Spring Conference 2025.
The conference is scheduled for March 25-26, 2025, with INBS management's presentation set for Tuesday, March 25th at 11:00 a.m. ET. The presentation will be accessible via webcast. Additionally, the company will conduct one-on-one meetings during the conference, which interested parties can schedule through iAccess representatives or by contacting KCSA Strategic Communications.
Intelligent Bio Solutions (Nasdaq: INBS), un'azienda di tecnologia medica focalizzata su soluzioni di test intelligenti, rapidi e non invasivi, ha annunciato la sua partecipazione alla prossima iAccess Alpha Virtual Best Ideas Spring Conference 2025.
La conferenza è programmata per 25-26 marzo 2025, con la presentazione della direzione di INBS fissata per martedì 25 marzo alle 11:00 ET. La presentazione sarà accessibile tramite webcast. Inoltre, l'azienda condurrà incontri individuali durante la conferenza, che le parti interessate possono pianificare attraverso i rappresentanti di iAccess o contattando KCSA Strategic Communications.
Intelligent Bio Solutions (Nasdaq: INBS), una empresa de tecnología médica centrada en soluciones de pruebas inteligentes, rápidas y no invasivas, ha anunciado su participación en la próxima iAccess Alpha Virtual Best Ideas Spring Conference 2025.
La conferencia está programada para 25-26 de marzo de 2025, con la presentación de la dirección de INBS programada para el martes 25 de marzo a las 11:00 a.m. ET. La presentación será accesible a través de un webcast. Además, la empresa llevará a cabo reuniones uno a uno durante la conferencia, que las partes interesadas pueden programar a través de representantes de iAccess o contactando a KCSA Strategic Communications.
Intelligent Bio Solutions (Nasdaq: INBS), 지능형, 신속하며 비침습적인 검사 솔루션에 중점을 둔 의료 기술 회사가 다가오는 iAccess Alpha Virtual Best Ideas Spring Conference 2025에 참여한다고 발표했습니다.
이번 컨퍼런스는 2025년 3월 25-26일로 예정되어 있으며, INBS 경영진의 발표는 3월 25일 화요일 오전 11:00 ET에 진행됩니다. 발표는 웹캐스트를 통해 접근할 수 있습니다. 또한, 회사는 컨퍼런스 기간 동안 일대일 회의를 진행하며, 관심 있는 당사자는 iAccess 대표를 통해 또는 KCSA Strategic Communications에 연락하여 일정을 잡을 수 있습니다.
Intelligent Bio Solutions (Nasdaq: INBS), une entreprise de technologie médicale axée sur des solutions de test intelligentes, rapides et non invasives, a annoncé sa participation à la prochaine iAccess Alpha Virtual Best Ideas Spring Conference 2025.
La conférence est prévue pour le 25-26 mars 2025, avec la présentation de la direction d'INBS fixée au mardi 25 mars à 11h00 ET. La présentation sera accessible par webcast. De plus, l'entreprise organisera des réunions individuelles pendant la conférence, que les parties intéressées peuvent planifier par l'intermédiaire des représentants d'iAccess ou en contactant KCSA Strategic Communications.
Intelligent Bio Solutions (Nasdaq: INBS), ein Medizintechnikunternehmen, das sich auf intelligente, schnelle und nicht-invasive Testlösungen konzentriert, hat seine Teilnahme an der bevorstehenden iAccess Alpha Virtual Best Ideas Spring Conference 2025 angekündigt.
Die Konferenz ist für 25.-26. März 2025 geplant, wobei die Präsentation des Managements von INBS für Dienstag, den 25. März um 11:00 Uhr ET angesetzt ist. Die Präsentation wird über ein Webcast zugänglich sein. Darüber hinaus wird das Unternehmen während der Konferenz Einzelgespräche führen, die interessierte Parteien über iAccess-Vertreter oder durch Kontaktaufnahme mit KCSA Strategic Communications planen können.
- None.
- None.
NEW YORK, March 11, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that its management team will participate in the iAccess Alpha Virtual Best Ideas Spring Conference 2025 on March 25 and 26, 2025.
iAccess Alpha Virtual Conference Details:
Date: March 25-26, 2025
Presentation Day and Time: Tuesday, March 25th at 11:00 a.m. ET
Webcast: https://www.webcaster4.com/Webcast/Page/3083/52118
INBS will also conduct one-on-one meetings during the conference. To schedule a meeting with management, please contact your representatives at iAccess or email KCSA Strategic Communications at INBS@KCSA.com.
About Intelligent Bio Solutions Inc.
Intelligent Bio Solutions Inc. (NASDAQ: INBS) is a medical technology company delivering innovative, rapid, non-invasive testing solutions. The Company believes that its Intelligent Fingerprinting Drug Screening System will revolutionize portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields. Designed as a hygienic and cost-effective system, the test screens for the recent use of drugs commonly found in the workplace, including opiates, cocaine, methamphetamine, and cannabis. With sample collection in seconds and results in under ten minutes, this technology would be a valuable tool for employers in safety-critical industries. The Company’s current customer segments outside the US include construction, manufacturing and engineering, transport and logistics firms, drug treatment organizations, and coroners.
For more information, visit: http://www.ibs.inc/
Company Contact:
Intelligent Bio Solutions Inc.
info@ibs.inc
LinkedIn | Twitter
Investor & Media Contact:
Valter Pinto, Managing Director
KCSA Strategic Communications
PH: (212) 896-1254
INBS@kcsa.com
FAQ
When is Intelligent Bio Solutions (INBS) presenting at the iAccess Alpha Conference 2025?
How can investors attend the INBS presentation at the iAccess Conference?
What type of meetings is INBS offering during the iAccess Conference 2025?
What is the main business focus of INBS according to the conference announcement?
